Category

Archives

Alcohol induces neural tube defects by reducing retinoic acid signaling and promoting neural plate expansion

Introduction: Neural tube defects (NTDs) are among the most debilitating and common developmental defects in humans. The induction of NTDs has been attributed to abnormal folic acid (vitamin B9) metabolism, Wnt and BMP signaling, excess retinoic acid (RA), dietary components, environmental factors, and many others. In the present study we show that reduced RA signaling, including alcohol exposure, induces NTDs. 

Methods: Xenopus embryos were exposed to pharmacological RA biosynthesis inhibitors to study the induction of NTDs. Embryos were treated with DEAB, citral, or ethanol, all of which inhibit the biosynthesis of RA, or injected to overexpress Cyp26a1 to reduce RA. NTD induction was studied using neural plate and notochord markers together with morphological analysis. Expression of the neuroectodermal regulatory network and cell proliferation were analyzed to understand the morphological malformations of the neural plate. 

Results: Reducing RA signaling levels using retinaldehyde dehydrogenase inhibitors (ethanol, DEAB, and citral) or Cyp26a1-driven degradation efficiently induce NTDs. These NTDs can be rescued by providing precursors of RA. We mapped this RA requirement to early gastrula stages during the induction of neural plate precursors. This reduced RA signaling results in abnormal expression of neural network genes, including the neural plate stem cell maintenance genes, geminin, and foxd4l1.1. This abnormal expression of neural network genes results in increased proliferation of neural precursors giving rise to an expanded neural plate. 

Conclusion: We show that RA signaling is required for neural tube closure during embryogenesis. RA signaling plays a very early role in the regulation of proliferation and differentiation of the neural plate soon after the induction of neural progenitors during gastrulation. RA signaling disruption leads to the induction of NTDs through the mis regulation of the early neuroectodermal network, leading to increased proliferation resulting in the expansion of the neural plate. Ethanol exposure induces NTDs through this mechanism involving reduced RA levels.

 

Comments:

Your study brings valuable insights into the induction of neural tube defects (NTDs) and the role of retinoic acid (RA) signaling in embryonic development. By utilizing Xenopus embryos and employing various inhibitors and molecular techniques, you successfully demonstrated the impact of reduced RA signaling in inducing NTDs. This reduction, facilitated by retinaldehyde dehydrogenase inhibitors and Cyp26a1 overexpression, led to morphological malformations in the neural plate.

Your findings highlight the criticality of RA signaling during early gastrula stages for the regulation of neural plate precursors' proliferation and differentiation. The disruption of this signaling pathway resulted in abnormal expression of neural network genes, such as geminin and foxd4l1.1, consequently leading to increased proliferation and an expanded neural plate, ultimately causing NTDs.

Notably, your study elucidates the link between ethanol exposure and NTD induction, revealing that ethanol operates through reducing RA levels, thus perturbing the neuroectodermal network and triggering abnormal proliferation in the neural precursors.

The identification of this mechanism underscores the significance of RA signaling in neural tube closure during embryogenesis and sheds light on how disruptions in this pathway contribute to NTDs. Furthermore, your research suggests potential avenues for intervention, such as providing RA precursors to rescue NTDs caused by reduced RA signaling.

Your study contributes significantly to our understanding of the intricate mechanisms underlying embryonic development and the etiology of NTDs, holding implications for potential preventive or therapeutic strategies in addressing these debilitating developmental defects.

Related Products

Cat.No. Product Name Information
S6132 All trans-Retinal All trans-Retinal (Retinaldehyde, Vitamin A aldehyde, Retinene), a component of the retinoid cycle, is converted to retinoic acid in vivo by the action of retinal dehydrogenase. Retinoic acid is a ligand for both RAR and RXR. All trans-retinal ias a potent photosensitizer.

Related Targets

Retinoid Receptor